LENZ Therapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Solana Beach, CA
LENZ chart
What traders are saying about $LENZ
Latest postsLENZ Therapeutics, Inc. news
- LENZ Therapeutics, Inc. (LENZ) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- LENZ Therapeutics, Inc. Estimates – NASDAQ:LENZ
TradingView ·
- Regeneron (REGN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Yahoo Finance ·
- LENZ Therapeutics to Report Third Quarter 2026 Financial Results on October 29, 2026
Yahoo Finance ·
- LENZ Therapeutics to report Q3 2026 financial r...
Pluang ·
- Millennium Management Reveals 3.7% Stake in LENZ Therapeutics via Schedule 13G Amendment
Kalkine Media ·
- TD Cowen maintains Buy rating on LENZ Therapeutics, $50 price target
TradingView ·
- LENZ Therapeutics (LENZ) Stock Fair Value Falls After Analysts Cut VIZZ Launch Expectations
Yahoo Finance ·
- LENZ Therapeutics (LENZ) Stock Sees Fair Value Moves Lower After Analyst Target Cuts
Yahoo Finance ·
- LENZ Therapeutics Inc (LENZ) (Q2 2026) Earnings Call Highlights: VIZZ Launch Momentum ...
Yahoo Finance ·
- LENZ Therapeutics, Inc. Q2 2026 Earnings Call Summary
app.moby.co ·
- LENZ Therapeutics Q2 Earnings Call Highlights
marketbeat.com ·
LENZ Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $19.1M | $0 | – | – |
| Net income | -$82.1M | -$49.8M | -$70.0M | -$101.1M |
| Diluted EPS | $-2.85 | $-2.34 | $-35.71 | $-1.84 |
| Total assets (year end) | $305.9M | $215.3M | $70.4M | $321.9M |
| Cash and equivalents (year end) | $25.2M | $20.2M | $35.1M | $47.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About LENZ Therapeutics, Inc.
- Ticker
- LENZ (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Solana Beach, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1815776
- Former names
- Graphite Bio, Inc.
Frequently asked questions
What exchange is LENZ Therapeutics, Inc. listed on?
LENZ Therapeutics, Inc. trades on the Nasdaq under the ticker symbol LENZ.
What industry is LENZ Therapeutics, Inc. in?
LENZ Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is LENZ Therapeutics, Inc. headquartered?
LENZ Therapeutics, Inc.'s business address on file with the SEC is in Solana Beach, CA.
When does LENZ Therapeutics, Inc.'s fiscal year end?
LENZ Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did LENZ Therapeutics, Inc. report?
LENZ Therapeutics, Inc. reported $19.1M in revenue for calendar year 2025, according to its SEC filings.